Successful treatment of right-sided prosthetic valve endocarditis due to methicillin-resistant teicoplanin-heteroresistant Staphylococcus aureus with linezolid

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 24, Issue 11, 2005, Pages 760-762

  Souli, M ^a   Pontikis, K ^a   Chryssouli, Z ^a   Galani, I ^a   Giamarellou, H ^a  

^a University General Hospital   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; GENTAMICIN; LINEZOLID; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

AGED; ARTICLE; BACTEREMIA; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; CASE REPORT; DRUG BLOOD LEVEL; FOLLOW UP; HEART VALVE PROSTHESIS; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSTHESIS INFECTION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

ACETAMIDES; AGED; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG THERAPY, COMBINATION; ENDOCARDITIS, BACTERIAL; HEART VALVE PROSTHESIS; HUMANS; MALE; METHICILLIN RESISTANCE; OXAZOLIDINONES; PROSTHESIS-RELATED INFECTIONS; RIFAMPIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TEICOPLANIN; TREATMENT OUTCOME; TRICUSPID VALVE;

EID: 28644438542     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-005-0023-9     Document Type: Article

References (16)

1. Gopal V, Bisno AL, Silverblatt FJ (1976) Failure of vancomycin treatment in Staphylococcus aureus endocarditis. In vivo and in vitro observations. JAMA 236:1604-1606
2. Rotun SS, McMath V, Schoonmaker DJ, Maupin PS, Tenover FC, Hill BC, Ackman DM (1999) Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia. Emerg Infect Dis 5:147-149
3. Moore MR, Perdreau-Remington F, Chambers HF (2003) Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis. Antimicrob Agents Chemother 47:1262-1266
4. Howden BP, Ward PB, Charles PGP, Korman TM, Fuller A, du Cros P, Grabsch EA, Roberts SA, Robson J, Read K, Bak N, Hurley J, Johnson PDR, Morris AJ, Mayall BC, Grayson ML (2004) Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. Clin Infect Dis 38:521-528
5. Leung KT, Tong MK, Siu YP, Lam CS, Ng HL, Lee HK (2004) Treatment of vancomycin-intermediate Staphylococcus aureus endocarditis with linezolid. Scand J Infect Dis 36:483-485
6. Bannerman TL (2003) Staphylococci, micrococci and other catalase-positive cocci that grow aerobically In: Murray PR, Baron EJ, Jorgensen SH, Pfaller MA, Yolken RH (eds) Manual of clinical microbiology, American Society for Microbiology, Washington, DC, pp 384-404
7. National Committee for Clinical Laboratory Standards (2004) Performance standards for antimicrobial susceptibility testing, fourteenth informational supplement M100-S14. NCCLS, Wayne, PA
8. Louie L, Matsumura SO, Choi E, Louie M, Simor AE (2000) Evaluation of three rapid methods for detection of methicillin-resistance in Staphylococcus aureus. J Clin Microbiol 38:2170-2173
9. Liu C, Chambers HF (2003) Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance and critical assessment of diagnostic methods. Antimicrob Agents Chemother 47:3040-3045
10. Kaatz G, Seo SM, Dorman NJ, Lerner SA (1990) Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis. J Infect Dis 162:103-108
11. Brunet F, Vedel G, Dreyfus F, Vaxelaire JF, Giraud T, Schremmer B, Monsallier JF (1990) Failure of teicoplanin therapy in two neutropenic patients with staphylococcal septicemia who recovered after administration of vancomycin. Eur J Clin Microbiol Infect Dis 9:145-147
12. Shlaes DM, Slaes JH, Vincent S, Etter L, Fey PD, Goering RV (1993) Teicoplanin-resistant Staphylococcus aureus expresses a novel membrane protein and increases expression of penicillin-binding protein 2 complex. Antimicrob Agents Chemother 37:2432-2437
13. Hanaki H, Kuwahara-Arai K, Boyle-Vavra S, Daum RS, Labischinski H, Hiramatsu K (1998) Activated cell wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus in clinical strains Mu3 and Mu50. J Antimicrob Chemother 42:199-209
14. El Solh N, Davi M, Morvan A, Damon HA, Marty N, GISA group, RAISIN subgroup (2003) Characteristics of French methicillin-resistant Staphylococcus aureus isolates with decreased susceptibility or resistance to glycopeptides. J Antimicrob Chemother 52:691-694
15. MacKenzie F, Greig P, Morrison D, Edwards G, Gould IM (2002) Identification and characterization of teicoplanin-intermediate Staphylococcus aureus blood culture isolates in NE Scotland. J Antimicrob Chemother 50:689-697
16. Aucken HM, Ganner M, Murchan S, Cookson BD, Johnson AP (2002) A new UK strain of epidemic methicillin-resistant Staphylococcus aureus (EMRSA-17) resistant to multiple antibiotics. J Antimicrob Chemother 50:171-175